ABOUT FRONTLINE BIOVENTURES
Frontline BioVentures is a premier China-based venture capital firm specialize in the investment of innovative life science companies
We focus on business within strategic life science and technology areas promoted by the Chinese government.
Currently we manage two funds, a RMB denominated fund and a parallel USD fund, which offers structural flexibilities to best serve the needs of portfolio companies.
NEWS & EVENTS
- Frontline BioVentures and WuXi Healthcare Ventures Join Forces to Form 6 Dimensions Capital, a leading China and US Focused Investment Group Specializing in Healthcare and Life Sciences (18th May 2017, Shanghai, Hong Kong, Boston, San Francisco)
- Frontline BioVentures Announced Norman Chen to Join as Venture Partner (6th Apr. 2017)
- Frontline BioVentures’ Total AUM Reached RMB 3Bn after Announcing RMB Fund II Fundraising Closed (1st March. 2017)
SUBMIT BUSINESS PLANS
We’re actively seeking opportunities to partner with committed and visionary entrepreneur to fuel innovative businesses in China’s life sciences sectors.
We welcome you to submit an executive summary of organized business plan to us via email below, and we will revert to you soon if we’re interested to explore more details.